Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
FATIGUE AND OTHER SYMPTOMS FOL...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
FATIGUE AND OTHER SYMPTOMS FOLLOWING INTRAVENOUS ZOLEDRONATE THERAPY
Bibliographic Details
Main Authors:
Warburton, S
,
Jess, C
,
Javaid, M
,
Wass, J
Format:
Conference item
Published:
2009
Holdings
Description
Similar Items
Staff View
Similar Items
FAILURE OF P1NP SUPPRESSION FOLLOWING INTRAVENOUS ZOLEDRONATE: EFFECT OF DEFINITIONS, DOSE, VITAMIN D STATUS, AND BMI
by: Warburton, S, et al.
Published: (2009)
SEVERE ADVERSE EVENT AFTER USE OF IV ZOLEDRONATE IN A PATIENT WITH MASTOCYTOSIS: A CASE REPORT
by: Jess, C, et al.
Published: (2009)
Preserving hip bone mineral density following stroke using intravenous zoledronic acid: Findings from a 1 year randomised controlled trial
by: Poole, K, et al.
Published: (2004)
Zoledronate prevents bone loss after stroke
by: Poole, K, et al.
Published: (2006)
A single infusion of zoledronate prevents bone loss after stroke.
by: Poole, K, et al.
Published: (2007)